IL2 and neoplasm: The finding that OKT3/IL-2 T cells have an more differentiated phenotype and an increased in vitro lytic ability suggests that these T cells may have more potent anti-tumor activity if they are locally administered, such as in a situation where direct anti-tumor potency is more important than migration and proliferation.